J. Goldman & Co’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-52,500
Closed -$196K 511
2022
Q1
$353K Buy
+52,500
New +$449K 0.02% 303
2018
Q1
Sell
-12,000
Closed -$196K 463
2017
Q4
$196K Buy
+12,000
New +$232K 0.01% 298
2017
Q2
Sell
-29,200
Closed -$896K 438
2017
Q1
$896K Buy
+29,200
New +$825K 0.04% 255

Other funds holding DBD

J. Goldman & Co's DBD Position: Q2 2022 in Review

J. Goldman & Co sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2022, closing a stake of 52,500 shares — an estimated $196K sold.

J. Goldman & Co first reported a position in DBD in Q1 2017 and held it in 3 quarters. The position peaked at $896K in Q1 2017. 169 funds tracked by Wall St. Rank hold DBD as of Q2 2022.

  • J. Goldman & Co reported no remaining Diebold Nixdorf Incorporated position as of Q2 2022 after selling out during the quarter.
  • J. Goldman & Co sold 52,500 Diebold Nixdorf Incorporated shares in Q2 2022, an estimated $196K.
  • J. Goldman & Co first reported a position in Diebold Nixdorf Incorporated in Q1 2017 and held it in 3 quarters.
  • J. Goldman & Co's Diebold Nixdorf Incorporated position peaked at $896K in Q1 2017.
  • 169 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2022.

Based on J. Goldman & Co's 13F filing for Q2 2022, filed 15 Aug 2022.